The origin and dynamics of cellular heterogeneity vary across lineage subtypes of castrate resistant prostate cancer
Michael L. Beshiri(National Cancer Institute), Kathleen Kelly(The Ohio State University)
Cited by 3
Related Papers
Cell-specific regulation of the c-myc gene by lymphocyte mitogens and platelet-derived growth factor
|Cell|1983|2.3k
Activity of durvalumab plus olaparib in metastatic castration-resistant prostate cancer in men with and without DNA damage repair mutations
|Journal for ImmunoTherapy of Cancer|2018|312
Tumor-derived biomarkers predict efficacy of B7H3 antibody-drug conjugate treatment in metastatic prostate cancer models
|Journal of Clinical Investigation|2023|28